文献速递其他结缔组织病自身炎症与 IgG4 相关病

局部硫代硫酸钠治疗异位钙化和骨化的疗效:CATSS-O 研究结果

Effectiveness of topical sodium thiosulfate for ectopic calcifications and ossifications. Results of the CATSS-O study.
PubMed 文献 · Semin Arthritis Rheum · 2023-11-04

CATSS-O 注册研究回顾性分析 126 例接受 25% 局部硫代硫酸钠治疗的患者,35 例有完整临床和影像数据可分析(28 例异位钙化,7 例骨化;18 名儿童,17 名成人)。局部硫代硫酸钠对异位钙化的临床有效率为 32.1%(9/28),对儿童骨化为 28.6%(2/7);儿童异位钙化疗效优于成人(54.5% vs 17.6%,p=0.035),耐受性良好。

要点

  • 35 例可分析患者中,局部 25% 硫代硫酸钠对异位钙化临床有效 9/28(32.1%),对儿童骨化有效 2/7(28.6%)。
  • 儿童异位钙化疗效优于成人(54.5% vs 17.6%,p=0.035)。
  • 3 例患者钙化完全消失,局部硫代硫酸钠耐受性良好。

核心结论

  • 局部硫代硫酸钠似乎对骨化有效,尤其是儿童钙化或骨化;需要随机和实验研究来证实这一观察并明确潜在机制。

研究设计与样本

  • CATSS-O 注册研究的回顾性分析,纳入 2014-2020 年期间接受利摩日医院药房配制的 25% 局部硫代硫酸钠治疗的患者。
  • 126 例接受 25% 硫代硫酸钠治疗的患者中,35 例有完整临床和影像数据可分析(28 例异位钙化,7 例骨化;18 名儿童平均年龄 8.9 岁,范围 1.5-16 岁;17 名成人平均年龄 52.4 岁,范围 24-90 岁)。
  • 疗效通过至少治疗 6 个月后的影像学(X 线或 CT)评估。

主要发现

  • 钙化或骨化病因包括皮肌炎(8 名儿童、6 名成人)、系统性硬皮病(6 名成人)或假性甲状旁腺功能减退症 1A 型(7 名儿童)。
  • 病灶为单发(37.1%)或多发(62.9%);治疗区域位于下肢(31.4%)、上肢(37.1%)或上下肢均有(28.6%)及中轴区域(2.9%)。
  • 局部硫代硫酸钠对异位钙化患者临床有效 9/28(32.1%),对骨化儿童有效 2/7(28.6%)。
  • 3 例患者钙化完全消失。
  • 异位钙化疗效儿童优于成人(54.5% vs 17.6%,p=0.035)。

局限性

  • 原文为回顾性分析。
  • 126 例接受治疗患者中仅 35 例有完整临床和影像数据可分析。
  • 原文结论指出需要随机和实验研究来证实这一观察并明确潜在机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Ectopic calcifications (ECs) and heterotopic ossifications (HOs) form in non-mineralized tissues, most often in subcutaneous and muscular areas. Local and systemic complications can cause severe disability. Systemic administration of sodium thiosulfate (STS) gives promising results but is difficult to use in clinical practice. OBJECTIVE: Evaluation of the efficacy and safety of topical STS in ECs and HOs. METHODS: Retrospective analysis of the CATSS-O registry that included patients receiving topical STS 25 % prepared by the pharmacy of Limoges hospital during 2014-2020. The efficacy of STS was assessed by imaging (radiography or CT) after at least 6 months' treatment. RESULTS: Among 126 patients who received STS 25 %, 35 had complete clinical and radiographic data for analysis (28 with ECs and 7 with HOs; 18 children [mean age 8.9 years, range 1.5-16], 17 adults [mean age 52.4 years, range 24-90]). Calcifications or ossifications were due to dermatomyositis (8 children, 6 adults), systemic scleroderma (6 adults) or pseudo-hypoparathyroidism 1A (7 children). They were single (37.1 %) or multiple (62.9 %). Treated regions were in the lower limbs (31.4 %), upper limbs (37.1 %) or both (28.6 %) and the axial region (2.9 %). Topical STS was clinically effective in 9/28 (32.1 %) patients with ECs and 2/7 (28.6 %) children with HOs. Three patients experienced complete disappearance of their calcifications. Response for ECs was better in children than adults (54.5% vs 17.6 %, p = 0.035). Topical STS was well tolerated. CONCLUSION: Local STS seems effective for ossifications, particularly pediatric calcifications or ossifications. Randomized and experimental studies are needed to confirm this observation and to identify the underlying mechanisms.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Gauffenic A, Ratsimbazafy V, Ostertag A, et al. Effectiveness of topical sodium thiosulfate for ectopic calcifications and ossifications. Results of the CATSS-O study. Semin Arthritis Rheum. 2023. PMID: 37976811. doi:10.1016/j.semarthrit.2023.152306

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。